Table 1.
Classification of countries according to CRC screening offer in years 2013–2015 and 2018–2020
| Screening Offer | Offer in 2018–2020 | ||||||
|---|---|---|---|---|---|---|---|
| None | Small scale organized program with fecal tests | Opportunistic gFOBT/FIT only | Opportunistic gFOBT/FIT or colonoscopy | Organized gFOBT/FIT (partial) | Organized gFOBT/FIT (full) | ||
|
Offer in 2013–2015 |
None | Bulgaria (50–74) | Estonia (50–74) | NA | Luxembourg [50–54] | Hungary (50–69)/[50–74] | Slovenia (70–74) |
| Cyprus (50–74) | Hungary (70–74) | Luxembourg [55–74] | Ireland (55–59, 70–74) | ||||
| Norway (50–74) | - | - | Malta (65–74) | ||||
| Poland (50–74) | - | ||||||
| Romania (50–74) | |||||||
| Small scale organized program with fecal tests | NA | NA | NA | NA | NA | NA | |
| Opportunistic gFOBT/FIT only | NA | NA | Latvia (50–74) | NA | NA | NA | |
| Opportunistic gFOBT/FIT or colonoscopy | NA | Luxembourg (50–74) | NA | Austria (50–74) | Czechia (50–74) | NA | |
| - | Germany (50–74) | Portugal (50–74) | |||||
| Greece (50–74) | - | ||||||
| Iceland (50–74) | |||||||
| Slovakia (50–74) | |||||||
| Organized gFOBT/FIT only (partial) | Finland (60–69)/[60–74] | NA | NA | NA | Ireland (60–69)/[60–74] | Belgium (50–74) | |
| Italy (50–69)/[50–74] | Denmark (50–74) | ||||||
| Malta (55–64)/[55–69] | Lithuania (50–74) | ||||||
| Spain (50–69)/[50–74] | Netherlands (55–74) | ||||||
| Sweden (60–69)/[60–74] | - | ||||||
| Organized gFOBT/FIT only (full) | NA | NA | NA | NA | Croatia (50–74) | ||
| Slovenia (50–69)/[50–74] | |||||||
Age groups in bold font and square bracket indicate the age group included in analysis of colonoscopy use and use of either test. gFOBT, guaiac-based fecal occult blood test; FIT, fecal immunochemical test; NA, not applicable